Concepedia

Lina Ekerljung

LE

Statistics

Publications

5

Citations

175

H-Index

5

Active since

2006

Affiliations

Uppsala University(Current)

Affibody (Sweden)

Uppsala University Hospital

Ludwig Cancer Research

KTH Royal Institute of Technology

Lina Ekerljung is an author at Uppsala University specializing in molecular oncology, oncology, and medicine.

Publications per year

2006–2012

5

Publications

5

Engineering and characterization of a bispecific HER2 × EGFR‐binding affibody molecule

Mikaela Friedman, Sara Lindström, Lina Ekerljung et al. · Biotechnology and Applied Biochemistry · 2009 · 66 citations · Full text

, , +17

Dimeric HER2-specific affibody molecules inhibit proliferation of the SKBR-3 breast cancer cell line

Lina Ekerljung, Malin Lindborg, Lars Gedda et al. · Biochemical and Biophysical Research Communications · 2008 · 40 citations

, , +13

Generation and Evaluation of Bispecific Affibody Molecules for Simultaneous Targeting of EGFR and HER2

Lina Ekerljung, Helena Wållberg, Azita Sohrabian et al. · Bioconjugate Chemistry · 2012 · 27 citations

, , +17

Effects of HER2-Binding Affibody Molecules on Intracellular Signaling Pathways

Lina Ekerljung, Ann-Charlott Steffen, J Carlsson et al. · Tumor Biology · 2006 · 25 citations

, , +17

The HER2-Binding Affibody Molecule (ZHER2∶342)2 Increases Radiosensitivity in SKBR-3 Cells

Lina Ekerljung, Johan Lennartsson, Lars Gedda · PLoS ONE · 2012 · 17 citations · Full text

, , +16

1–5 of 5